Effects of milk casein derived tripeptides on endothelial enzymes in vitro; A study with synthetic tripeptides

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 10, 2012, Pages 477-481

  Siltari, A ^a   Kivimaki A S ^a   Ehlers, P I ^a   Korpela, R ^a   Vapaatalo, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

blood pressure; cathepsin G; endothelium; prolyl oligopeptidase; renin angiotensin system; tripeptide

Indexed keywords

ANTIHYPERTENSIVE AGENT; CASEIN; CATHEPSIN G; CHYMASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; ISOLEUCINE; ISOLEUCINE PROLINE PROLINE; LEUCINE PROLINE PROLINE; MEMBRANE METALLOENDOPEPTIDASE; PROLINE; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; RENIN; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VALINE PROLINE PROLINE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; MILK; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AREA UNDER CURVE; ASPARTIC ACID ENDOPEPTIDASES; BLOOD PRESSURE; CASEINS; CATHEPSIN G; CHYMASES; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; METALLOENDOPEPTIDASES; NEPRILYSIN; OLIGOPEPTIDES; PROTEASE INHIBITORS; RENIN; SERINE ENDOPEPTIDASES;

EID: 84867755653     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0032-1321846     Document Type: Article

References (26)

1. Varagic J., Trask A. J., Jessup J. A. et al. New angiotensins. J Mol Med: 2008; 86 663 671
2. Fyhrqvist F., Saijonmaa O. Renin-angiotensin system revisited. J Intern Med: 2008; 264 224 236
3. Katovich M. J., Grobe J. L., Raizada M. K. Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr Hypertens Rep: 2008; 10 227 232
4. Cat AN D., Touyz RM A. New look at the renin-angiotensin system- focusing on the vasculature system. Peptides: 2011; 32 2141 2150
5. Ehlers P. I., Nurmi L., Turpeinen A. M. et al. Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation. Life Sci: 2011; 88 206 211
6. Nakamura Y., Yamamoto N., Sakai K. et al. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci: 1995; 78 777 783
7. Sipola M., Finckenberg P., Santisteban J. et al. Long-term intake of milk peptide attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol: 2001; 52 745 754
8. Jäkälä P., Jauhiainen T., Korpela R. et al. Milk protein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro protect endothelial function in vitro in hypertensive rats. J Functional Foods: 2009; 1 266 273
9. Jäkälä P., Pere E., Lehtinen R. et al. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J Physiol Pharmacol: 2009; 60 11 20
10. Pripp A. H. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res: 2008; 32 10.3402/fnr.v52i0.1641
11. Xu J. Y., Qin L. Q., Wang P. Y. et al. Effects of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition: 2008; 24 933 940
12. Cicero A. F., Gerocarni B., Laghi L. et al. Blood pressure lowering effects of lactotripeptides assumed as functional food: a meta-analysis of current available clinical trials. J Hum Hypertens: 2011; 25 425 436
13. Lehtinen R., Jauhiainen T., Kankuri E. et al. Effects of milk casein-derived tripeptides Ile-Pro-Pro, Val-Pro-Pro, and Leu-Pro-Pro on enzymes processing vasoactive precursors in vitro. Aznelmittelforschung: 2010; 60 182 185
14. Florentin D., Sassi A., Roques B. P. A highly sensitive fluorometric assay for enkephalinase, a neutral metallopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem: 1984; 141 62 69
15. Atack J. R., Suman-Chauhan N., Dawson G. et al. In vitro and in vivo inhibition of prolyl endopeptidase. Eur J Pharm: 1991; 205 157 163
16. Stanziola L., Greene L. J., Santos R. A. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am J Hypert: 1999; 12 1021 1029
17. Barrett A. J., Cathepsin G. Meth in Enzym: 1981; 80 561 565
18. Greene L. J., Spadaro A. C., Martins A. et al. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension: 1982; 4 178 184
19. Ward P. E., Bausback H. H., Odya C. E. Kinin and angiotensin metabolism by purified renal post-proline cleaving enzymes. Biochem Pharmacol: 1987; 36 3187 3193
20. Jauhiainen T., Wuolle K., Vapaatalo H. et al. Oral absoption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. Int Dairy J: 2007; 17 1216 1223
21. Koida M., Walter R. Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem: 1976; 251 7593 7599
22. Yoshimoto T., Nishimura T., Takatsuka N. et al. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain. J Biochem: 1983; 94 1179 1190
23. Stanziola L., Greene L. J., Santos RA S. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am J Hypertens: 1999; 12 1021 1029
24. Lawandi J., Gerber-Lemaire S., Juillerat-Jeanneret L. et al. Inhibitors of prolyl oligopeptidases for the therapy of human disease: Defining diseases and inhibitors. J Med Chem: 2010; 53 3423 3438
25. Carcia-Horsman J. A., Männistö P. T., Venäläinen J. I. On the role of prolyl oligopeptidase on health and disease. Neuropeptides: 2007; 41 1 24
26. Brecher A. S., Dubord R. Effect on acetaldehyde upon cathepsin G and chymase. NRAS implications. Dig Dis Sci: 2008; 53 1311 1315